JP2004513074A5 - - Google Patents

Download PDF

Info

Publication number
JP2004513074A5
JP2004513074A5 JP2002509771A JP2002509771A JP2004513074A5 JP 2004513074 A5 JP2004513074 A5 JP 2004513074A5 JP 2002509771 A JP2002509771 A JP 2002509771A JP 2002509771 A JP2002509771 A JP 2002509771A JP 2004513074 A5 JP2004513074 A5 JP 2004513074A5
Authority
JP
Japan
Prior art keywords
fragment
tumor
determined
antibody
ovarian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002509771A
Other languages
English (en)
Japanese (ja)
Other versions
JP5165827B2 (ja
JP2004513074A (ja
Filing date
Publication date
Priority claimed from EP00114788A external-priority patent/EP1172654B1/en
Application filed filed Critical
Publication of JP2004513074A publication Critical patent/JP2004513074A/ja
Publication of JP2004513074A5 publication Critical patent/JP2004513074A5/ja
Application granted granted Critical
Publication of JP5165827B2 publication Critical patent/JP5165827B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002509771A 2000-07-10 2001-07-10 卵巣腫瘍および子宮内膜腫瘍に対するl1接着分子に基づく卵巣腫瘍または子宮内膜腫瘍の検出方法 Expired - Fee Related JP5165827B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00114788A EP1172654B1 (en) 2000-07-10 2000-07-10 Diagnostic method based on the detection of the L1 adhesion molecule for ovarian and endometrial tumors
EP00114788.3 2000-07-10
PCT/EP2001/007924 WO2002004952A2 (en) 2000-07-10 2001-07-10 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors

Publications (3)

Publication Number Publication Date
JP2004513074A JP2004513074A (ja) 2004-04-30
JP2004513074A5 true JP2004513074A5 (cg-RX-API-DMAC7.html) 2008-09-04
JP5165827B2 JP5165827B2 (ja) 2013-03-21

Family

ID=8169210

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002509771A Expired - Fee Related JP5165827B2 (ja) 2000-07-10 2001-07-10 卵巣腫瘍および子宮内膜腫瘍に対するl1接着分子に基づく卵巣腫瘍または子宮内膜腫瘍の検出方法

Country Status (10)

Country Link
US (2) US7618785B2 (cg-RX-API-DMAC7.html)
EP (2) EP1172654B1 (cg-RX-API-DMAC7.html)
JP (1) JP5165827B2 (cg-RX-API-DMAC7.html)
CN (1) CN1479871A (cg-RX-API-DMAC7.html)
AT (1) ATE377192T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001285820A1 (cg-RX-API-DMAC7.html)
CA (1) CA2415364C (cg-RX-API-DMAC7.html)
DE (1) DE60036935T2 (cg-RX-API-DMAC7.html)
ES (1) ES2296586T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002004952A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2296586T3 (es) * 2000-07-10 2008-05-01 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Metodo de diagnostico basado en la deteccion de la molecula de adhesion l1 para tumores de ovario y el endometrio.
US6852874B2 (en) 2000-10-02 2005-02-08 The Scripps Research Institute Second cycle asymmetric dihydroxylation reaction
EP1623995A1 (en) 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Inhibitors of L1 and ADAM10 for the treatment of carcinomas
WO2007114550A1 (en) * 2006-04-03 2007-10-11 Korea Research Institute Of Bioscience And Biotechnology A novel monoclonal antibody specific to the l1cam, a hybridoma producing the same and a method producing the same
AU2007288620B2 (en) 2006-08-23 2012-08-30 Korea Research Instititute Of Bioscience And Biotechnology A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma
WO2008151819A2 (en) * 2007-06-15 2008-12-18 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Treatment of tumors using specific anti-l1 antibody
AU2008201871A1 (en) * 2008-04-16 2009-11-26 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Inhibition of angiogenesis and tumor metastasis
KR20100060351A (ko) 2008-11-27 2010-06-07 한국생명공학연구원 L1cam의 활성 또는 발현을 억제하는 물질 및 항암제를포함하는 항암용 조성물
KR101504039B1 (ko) * 2012-11-16 2015-03-19 강원대학교산학협력단 인간 및 마우스 l1cam 단백질에 특이적으로 결합하는 항체 및 이의 용도
KR20250140647A (ko) * 2020-08-03 2025-09-25 난트셀, 인크. Il-15 초작용제에 대한 약물-특이적 약동학 검정

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939240A (en) * 1983-03-04 1990-07-03 Health Research, Inc. Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy
GB2339200B (en) * 1998-06-06 2001-09-12 Genostic Pharma Ltd Genostics
ES2296586T3 (es) * 2000-07-10 2008-05-01 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Metodo de diagnostico basado en la deteccion de la molecula de adhesion l1 para tumores de ovario y el endometrio.
US20020115065A1 (en) * 2000-08-28 2002-08-22 Ton Logtenberg Differentially expressed epitopes and uses thereof
EP1399850A2 (en) * 2001-02-21 2004-03-24 The Board of Regents of The University of Oklahoma Hla ligand database utilizing predictive algorithms and methods of making and using same

Similar Documents

Publication Publication Date Title
Macanovic et al. Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay
Ahmed et al. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer
US8329410B2 (en) Method for diagnosing kidney disease comprising detecting the level of annexin A2
AU2014232155B2 (en) SRM assay to indicate cancer therapy
SG169395A1 (en) Detection of cancer by elevated levels of bcl-2
Cho et al. Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis
JP2005531321A5 (cg-RX-API-DMAC7.html)
Lin et al. Deep depletion of abundant serum proteins reveals low‐abundant proteins as potential biomarkers for human ovarian cancer
JP2012509477A5 (cg-RX-API-DMAC7.html)
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
JP2013524251A (ja) 妊娠高血圧疾患のバイオマーカー
WO2007082144A2 (en) B7-h1 and survivin in cancer
US20040219597A1 (en) Use of soluble cytokeratin-1-fragments in diagnostics and therapy
WO2012027631A2 (en) Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells
AU2017251859A1 (en) SRM/MRM assay for subtyping lung histology
Kulka et al. Detection of HER-2/neu gene amplification in breast carcinomas using quantitative real-time PCR—a comparison with immunohistochemical and FISH results
AU2015203904B2 (en) SRM assay for PD-L1
JP2003524017A5 (cg-RX-API-DMAC7.html)
AU2017203160A1 (en) Bcl-2-like protein 11 srm/mrm assay
Huber et al. Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer
JP2004504327A5 (cg-RX-API-DMAC7.html)
Kim et al. Expression of the HMGI (Y) gene in human colorectal cancer
Sjöström Predictive factors for response to chemotherapy in advanced breast cancer
KR101096487B1 (ko) 자폐증의 진단
EP1159614A4 (en) DIAGNOSTIC METHOD FOR ASTHMA